Cargando…
Cell-free microRNA-1246 in different body fluids as a diagnostic biomarker for esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma is a malignant tumor with unfavorable prognosis. In this study, we investigated the usefulness of microRNA (miR)-1246 detection in various body fluids as a biomarker for this disease. A total of 72 patients with esophageal squamous cell carcinoma were enrolled, and...
Autores principales: | Hoshino, Isamu, Ishige, Fumitaka, Iwatate, Yosuke, Gunji, Hisashi, Kuwayama, Naoki, Nabeya, Yoshihiro, Yokota, Hajime, Takeshita, Nobuyoshi, Iida, Keiko, Nagase, Hiroki, Matsubara, Hisahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946279/ https://www.ncbi.nlm.nih.gov/pubmed/33690683 http://dx.doi.org/10.1371/journal.pone.0248016 |
Ejemplares similares
-
Usefulness of serum miR-1246/miR-106b ratio in patients with esophageal squamous cell carcinoma
por: Hoshino, Isamu, et al.
Publicado: (2020) -
Radiogenomics predicts the expression of microRNA-1246 in the serum of esophageal cancer patients
por: Hoshino, Isamu, et al.
Publicado: (2020) -
MIR1246 in body fluids as a biomarker for pancreatic cancer
por: Ishige, Fumitaka, et al.
Publicado: (2020) -
Inducing multiple antibodies to treat squamous cell esophageal carcinoma
por: Hoshino, Isamu, et al.
Publicado: (2020) -
Prognostic impact of p53 and/or NY‐ESO‐1 autoantibody induction in patients with gastroenterological cancers
por: Hoshino, Isamu, et al.
Publicado: (2020)